Linnaeus Therapeutics, Inc.
Biotechnology · Haddonfield, NJ, United States
- CompanyLinnaeus Therapeutics, Inc.Haddonfield, NJ, United States
- Phone line+1 (856) 433-1500General business
Linnaeus Therapeutics, Inc. is a privately held biotechnology company based in Haddonfield, NJ that filed a Form D exempt offering notice with the SEC on 31-MAR-2026.
Capabilities
Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. Form D industry group: Biotechnology — SEC Form D data sets (private offerings)
People 6
Chair & board
Chris ArendtDirector
James DemetriadesDirector
John LeppingDirector
Michael PoiselDirector
Everyone else on file (1)
Patrick MooneyExecutive Officer, Director
Source timeline
Record created from SEC Form D data sets (private offerings)
SEC Form D data sets (private offerings) ↗Patrick Mooney — Executive Officer, Director
SEC Form D data sets (private offerings) ↗Chris Arendt — Director
SEC Form D data sets (private offerings) ↗James Demetriades — Director
SEC Form D data sets (private offerings) ↗John Lepping — Director
SEC Form D data sets (private offerings) ↗
Similar makers
enGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityLeef Brands Inc.Medicinal Chemicals & Botanical Products · Vancouver1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capability